Nguyen et al. elucidated a strategy to restore MHC-I expression in SCLC by inhibition of lysine-specific demethylase 1 (LSD1), which promotes immune activation and antitumor response to ICIs [167]. The gene discussed is KDM1A; the disease is small cell lung carcinoma.